Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and Norway

Awakn Life Sciences Corp. , a biotechnology company, researching, developing, and delivering revolutionary therapeutics to treat addiction, today is providing shareholders with a business update on... | April 13, 2022

Related Keywords

Norway ,Canada ,United States ,United Kingdom ,Toronto ,Ontario ,America ,American ,Anne Donohoe ,Celia Morgan ,Ben Sessa ,Linkedin Facebook ,Valter Pinto Tim Regan ,Paul Jarman Nora Popova ,Laurie Higbed ,James Collins ,Awakn Life Sciences ,Strategic Communications ,Newsfile Corp ,Awakn Life Sciences Corp ,Research Development ,Life Sciences ,Chief Medical Officer ,Lead Psychologist ,Ketamine Assisted Therapy ,Lowan Stewart ,Managing Director ,Awakn Clinics ,Chief Operating Officer ,Clinics Bristol ,Alcohol Use Disorder ,Clinics Oslo ,Awakn Clinics Oslo ,Clinics London ,American Journal ,Therapeutics Commercialization ,United States Securities Act ,Awakn Life Sciences Corp Stock Exchange ,News ,Information ,Press Release ,Awakn ,Life ,Ciences ,Biotechnology ,End ,Elivering ,Revolutionary ,Herapeutics ,O ,Treat ,Oday ,Us ,Roviding ,Shareholders ,Ith ,Business ,Pdate Awkn Ca05455w1086 ,